Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial - Desai, A S; Vardeny, O; Claggett, B (JAMA Cardiol, 2017)
. doi:10.1001/jamacardio.2016.4733